Literature DB >> 27288204

Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.

Braghadheeswar Thyagarajan1, Sayee Sundar Alagusundaramoorthy1, Lopa Shah2, Abhinav Agrawal1.   

Abstract

Richter's transformation is a rare clinical condition occurring in about 5-10% of patients with chronic lymphocytic leukaemia (CLL). Patients usually present with lymphadenopathy, hepatosplenomegaly and elevated serum lactate dehydrogenase levels. These patients have a very poor prognosis with a median survival of about 10 months. We present a patient, with a history of CLL in complete remission, who presented with splenic rupture requiring splenectomy. She was eventually diagnosed with diffuse large B-cell lymphoma with Richter's transformation. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27288204      PMCID: PMC4904402          DOI: 10.1136/bcr-2016-214361

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  [CHRONIC LYMPHOID LEUKEMIA SECONDARILY ASSOCIATED WITH A MALIGNANT RETICULOPATHY: RICHTER'S SYNDROME].

Authors:  P LORTHOLARY; M BOIRON; P RIPAULT; J P LEVY; A MANUS; J BERNARD
Journal:  Nouv Rev Fr Hematol       Date:  1964 Sep-Oct

Review 2.  A systematic review on Richter syndrome: what is the published evidence?

Authors:  Stefano Molica
Journal:  Leuk Lymphoma       Date:  2010-03

Review 3.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Preetesh Jain; Susan O'Brien
Journal:  Oncology (Williston Park)       Date:  2012-12       Impact factor: 2.990

4.  Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.

Authors:  Alexandar Tzankov; Dominic Fong
Journal:  Med Hypotheses       Date:  2005-10-11       Impact factor: 1.538

5.  Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia.

Authors:  Lei Fan; Li Wang; Run Zhang; Cheng Fang; Dan-Xia Zhu; Yin-Hua Wang; Zhi-Jian Zou; Jian-Yong Li; Wei Xu
Journal:  Leuk Lymphoma       Date:  2012-03-13

6.  IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.

Authors:  Zhengrong Mao; Leticia Quintanilla-Martinez; Mark Raffeld; Manfred Richter; Jens Krugmann; Christof Burek; Elena Hartmann; Thomas Rudiger; Elaine S Jaffe; Hans Konrad Müller-Hermelink; German Ott; Falko Fend; Andreas Rosenwald
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

7.  The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia.

Authors:  Yupo Ma; Adnan Mansour; B Nebiyou Bekele; Xian Zhou; Michael J Keating; Susan O'Brien; Francis J Giles; Maher Albitar
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

9.  Richter's syndrome: a report on 39 patients.

Authors:  L E Robertson; W Pugh; S O'Brien; H Kantarjian; C Hirsch-Ginsberg; A Cork; P McLaughlin; F Cabanillas; M J Keating
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

10.  Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.

Authors:  Apostolia M Tsimberidou; William G Wierda; Sijin Wen; William Plunkett; Susan O'Brien; Thomas J Kipps; Jeffrey A Jones; Xavier Badoux; Hagop Kantarjian; Michael J Keating
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.